Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a dominant cause of chronic liver disease, but the exact mechanism of progression from simple steatosis to nonalcoholic steatohepatitis (NASH) remains unknown. Here, we investigated the role of exosomes in NAFLD progression. Exosomes were isolated from a human hepatoma cell line treated with palmitic acid (PA) and their miRNA profiles examined by microarray. The human hepatic stellate cell (HSC) line (LX-2) was then treated with exosome isolated from hepatocytes. Compared with controls, PA-treated hepatocytes displayed significantly increased CD36 and exosome production. The microarray analysis showed there to be distinctive miRNA expression patterns between exosomes from vehicle- and PA-treated hepatocytes. When LX-2 cells were cultured with exosomes from PA-treated hepatocytes, the expression of genes related to the development of fibrosis were significantly amplified compared to those treated with exosomes from vehicle-treated hepatocytes. In conclusion, PA treatment enhanced the production of exosomes in these hepatocytes and changed their exosomal miRNA profile. Moreover, exosomes derived from PA-treated hepatocytes caused an increase in the expression levels of fibrotic genes in HSCs. Therefore, exosomes may have important roles in the crosstalk between hepatocytes and HSCs in the progression from simple steatosis to NASH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dying or damaged hepatocytes secrete damage-associated molecular patterns including high mobility group box 1 protein (HMGB1), osteopontin (SPP1), purinoceptor 14 (P2Y14) ligands, apoptotic bodies, microRNA (miRNA), and DNA that can be packaged into microvesicles and directly taken up by HSCs, leading to their activation into collagen-producing myofibroblasts (see “Cellular plasticity”, below) (23”
From Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH) (2023) · cites this paper as [28]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Self-citationYounossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Vernon, G., Baranova, A., & Younossi, Z. M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04724.x · Cited by 3,074
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Nonalcoholic Fatty Liver Disease: A Systematic Review
Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,267
Jung, U., & Choi, M.-S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046184 · Cited by 1,880
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Ling, H., Fabbri, M., & Calin, G. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4140 · Cited by 1,465
Colombo, M., Moita, C., van Niel, G., Kowal, J., Vigneron, J., Benaroch, P., Manel, N., Moita, L. F., Théry, C., & Raposo, G. (2013) · Journal of Cell Science · doi:10.1242/jcs.128868 · Cited by 1,463
Chang, J., Nicolas, E., Marks, D., Sander, C., Lerro, A., Buendia, M. A., Xu, C., Mason, W. S., Moloshok, T., Bort, R., et al. (2004) · RNA Biology · doi:10.4161/rna.1.2.1066 · Cited by 811
Wong, R. J., Cheung, R., & Ahmed, A. (2014) · Hepatology · doi:10.1002/hep.26986 · Cited by 723
Characterization and Comprehensive Proteome Profiling of Exosomes Secreted by Hepatocytes
Conde-Vancells, J., Rodriguez-Suarez, E., Embade, N., Gil, D., Matthiesen, R., Valle, M., Elortza, F., Lu, S. C., Mato, J. M., & Falcon-Perez, J. M. (2008) · Journal of Proteome Research · doi:10.1021/pr8004887 · Cited by 642
Bobrie, A., Colombo, M., Krumeich, S., Raposo, G., & Théry, C. (2012) · Journal of Extracellular Vesicles · doi:10.3402/jev.v1i0.18397 · Cited by 579
Pirola, C. J., Fernández Gianotti, T., Castaño, G. O., Mallardi, P., San Martino, J., Mora Gonzalez Lopez Ledesma, M., Flichman, D., Mirshahi, F., Sanyal, A. J., & Sookoian, S. (2015) · Gut · doi:10.1136/gutjnl-2014-306996 · Cited by 564
Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes
Hirsova, P., Ibrahim, S. H., Krishnan, A., Verma, V. K., Bronk, S. F., Werneburg, N. W., Charlton, M. R., Shah, V. H., Malhi, H., & Gores, G. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.037 · Cited by 507
Exosomes: New players in cell–cell communication
Bang, C., & Thum, T. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.08.007 · Cited by 505
The exosome pathway in K562 cells is regulated by Rab11
Savina, A., Vidal, M., & Colombo, M. I. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.12.2505 · Cited by 486
Inflammatory Pathways in Liver Homeostasis and Liver Injury
Tacke, F., Luedde, T., & Trautwein, C. (2009) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-008-8091-0 · Cited by 393
Inhibiting MicroRNA-192 Ameliorates Renal Fibrosis in Diabetic Nephropathy
Putta, S., Lanting, L., Sun, G., Lawson, G., Kato, M., & Natarajan, R. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011050485 · Cited by 368
Momen-Heravi, F., Bala, S., Kodys, K., & Szabo, G. (2015) · Scientific Reports · doi:10.1038/srep09991 · Cited by 347
Momen-Heravi, F., Saha, B., Kodys, K., Catalano, D., Satishchandran, A., & Szabo, G. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0623-9 · Cited by 307
Masyuk, A. I., Huang, B. Q., Ward, C. J., Gradilone, S. A., Banales, J. M., Masyuk, T. V., Radtke, B., Splinter, P. L., & LaRusso, N. F. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00093.2010 · Cited by 285
Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases
Masyuk, A. I., Masyuk, T. V., & LaRusso, N. F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.028 · Cited by 283
Povero, D., Eguchi, A., Li, H., Johnson, C. D., Papouchado, B. G., Wree, A., Messer, K., & Feldstein, A. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113651 · Cited by 272
Ding, J., Li, M., Wan, X., Jin, X., Chen, S., Yu, C., & Li, Y. (2015) · Scientific Reports · doi:10.1038/srep13729 · Cited by 261
Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells
Wobser, H., Dorn, C., Weiss, T. S., Amann, T., Bollheimer, C., Büttner, R., Schölmerich, J., & Hellerbrand, C. (2009) · Cell Research · doi:10.1038/cr.2009.73 · Cited by 238
Kornek, M., Lynch, M., Mehta, S. H., Lai, M., Exley, M., Afdhal, N. H., & Schuppan, D. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.031 · Cited by 203
Kranendonk, M. E. G., Visseren, F. L. J., van Herwaarden, J. A., Nolte-'t Hoen, E. N. M., de Jager, W., Wauben, M. H. M., & Kalkhoven, E. (2014) · Obesity · doi:10.1002/oby.20847 · Cited by 188
Sato, K., Meng, F., Glaser, S., & Alpini, G. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.03.004 · Cited by 186
The emerging roles of microvesicles in liver diseases
Lemoinne, S., Thabut, D., Housset, C., Moreau, R., Valla, D., Boulanger, C. M., & Rautou, P.-E. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.7 · Cited by 172
Pan, Q., Ramakrishnaiah, V., Henry, S., Fouraschen, S., de Ruiter, P. E., Kwekkeboom, J., Tilanus, H. W., Janssen, H. L. A., & van der Laan, L. J. W. (2012) · Gut · doi:10.1136/gutjnl-2011-300449 · Cited by 164
Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia
Ng, R., Wu, H., Xiao, H., Chen, X., Willenbring, H., Steer, C. J., & Song, G. (2014) · Hepatology · doi:10.1002/hep.27153 · Cited by 154
Becker, P. P., Rau, M., Schmitt, J., Malsch, C., Hammer, C., Bantel, H., Müllhaupt, B., & Geier, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142661 · Cited by 154
Polyzos, S. A., Kountouras, J., Zavos, C., & Deretzi, G. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31824587e0 · Cited by 152
Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis
Kitano, M., & Bloomston, P. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5030038 · Cited by 121
miRClassify: An advanced web server for miRNA family classification and annotation
Zou, Q., Mao, Y., Hu, L., Wu, Y., & Ji, Z. (2013) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2013.12.007 · Cited by 104
Aberrant Hepatic MicroRNA Expression in Nonalcoholic Fatty Liver Disease
Feng, Y., Xu, X. Q., Ji, C. B., Shi, C. M., Guo, X., & Fu, J. F. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366394 · Cited by 85
Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease
Ban, L., Shackel, N., & McLennan, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030376 · Cited by 75
McKee, C., Sigala, B., Soeda, J., Mouralidarane, A., Morgan, M., Mazzoccoli, G., Rappa, F., Cappello, F., Cabibi, D., Pazienza, V., et al. (2015) · Scientific Reports · doi:10.1038/srep08812 · Cited by 54
Hepatic immunophenotyping for streptozotocin-induced hyperglycemia in mice
Lee, Y., Eun, H. S., Kim, S. Y., Jeong, J., Seo, W., Byun, J.-S., Jeong, W., & Yi, H. (2016) · Scientific Reports · doi:10.1038/srep30656 · Cited by 30
Self-citationRecent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players
Vincent, R. J., & Sanyal, A. J. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-014-0049-8 · Cited by 22
Chriett, S., Huërou‐Luron, I. L., Vidal, H., & Pirola, L. (2016) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.12.028 · Cited by 19
Cited by
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine
Hade, M. D., Suire, C. N., & Suo, Z. (2021) · Cells · doi:10.3390/cells10081959 · Cited by 607
The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance
Watt, M. J., Miotto, P. M., De Nardo, W., & Montgomery, M. K. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00034 · Cited by 615
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Rada, P., González-Rodríguez, Á., García-Monzón, C., & Valverde, Á. M. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-03003-w · Cited by 518
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Geng, Y., Faber, K. N., de Meijer, V. E., Blokzijl, H., & Moshage, H. (2021) · Hepatology International · doi:10.1007/s12072-020-10121-2 · Cited by 432
Metadata
- Authors
- Lee, Y.-S., Kim, S. Y., Ko, E., Lee, J.-H., Yi, H.-S., Yoo, Y. J., Je, J., Suh, S. J., Jung, Y. K., Kim, J. H., Seo, Y. S., Yim, H. J., Jeong, W.-I., Yeon, J. E., Um, S. H., & Byun, K. S.
- Affiliations
- Korea University (KR)
- Korea Advanced Institute of Science and Technology (KR)
- Chungnam National University (KR)
- Corresponding author
- Yeon, Jong Eun
- ORCID
- Venue
- Scientific Reports
- Published
- 2017-06-16
- Volume
- 7
- Issue
- 1
- Pages
- 3710-3710
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5473841
- OpenAlex
- W2625576839
- Cited by
- 233
- References
- 44
- Citations by year
- 2026: 6 · 2025: 20 · 2024: 29 · 2023: 33 · 2022: 34 · 2021: 48 · 2020: 35 · 2019: 16 · 2018: 9 · 2017: 3
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Gilead Sciences
- National Research Foundation
- National Research Foundation of Korea (2015R1C1A1A01052360)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- exosomes, palmitic acid, hepatocytes, hepatic stellate cells, liver fibrosis, non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, microRNA, CD36
- MeSH terms
- Animals, Humans, Liver Cirrhosis, Male, Palmitic Acid, Gene Expression Profiling, Hepatocytes, MicroRNAs, Cell Line, Tumor, Mice, Hepatic Stellate Cells, Exosomes, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.